This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
| Yesterday’s UK 100 Leaders | Price (p) | % Chg |
| NMC HEALTH PLC | 854.2 | 9.8% |
| ANGLO AMERICAN PLC | 2,153.5 | 4.9% |
| ANTOFAGASTA PLC | 880.0 | 4.1% |
| BARRATT DEVELOPMENTS PLC | 856.4 | 3.6% |
| EVRAZ PLC | 405.0 | 3.3% |
| Yesterday’s UK 100 Laggards | Price (p) | % Chg |
| TUI AG-DI | 925.6 | -4.4% |
| OCADO GROUP PLC | 1209.5 | -3.6% |
| IMPERIAL BRANDS PLC | 1839.0 | -2.1% |
| POLYMETAL INTERNATIONAL PLC | 1271.0 | -1.8% |
| MELROSE INDUSTRIES PLC | 240.8 | -1.7% |
| Major World Indices | Price | % Chg | 1 Year |
| UK 100 INDEX | 7,534 | 0.5% | 4.8% |
| DOW JONES INDUS. AVG | 29,551 | 0.9% | 15.7% |
| DAX INDEX | 13,750 | 0.9% | 23.1% |
| NIKKEI 225 | 23,828 | -0.1% | 12.7% |
| S&P/ASX 200 INDEX | 7,103 | 0.2% | 17.2% |
| Commodities | Units | Price | % Chg |
| WTI Crude Oil (Nymex) | USD/bbl. | 51.15 | -0.04% |
| Brent Crude (ICE) | USD/bbl. | 55.66 | -0.23% |
| Gold Spot | USD/t oz. | 1,573 | 0.5% |
| Copper (Comex) | USd/lb. | 259 | -0.4% |
Click graph to enlarge
UK 100 called to open -33 points at 7501 (18.4 points of the fall are dividends); U.S. equity futures dropped along with most stock markets in Asia on Thursday as investors mulled over the implications of a surge in the number of coronavirus cases in China’s Hubei province, after it deployed a revised methodology. In Asian sharp initial falls were somewhat pared by the close, with the Nikkei closing down 33 points at 23,827 and the Hang Seng closing down just 71 points at 27,752. This followed on from a very buoyant trading session in the US which saw the Dow Jones trading once again towards record highs having added 275 points to close at 29,551, the S&P saw a similar percentage gain to close at 3,379, a gain of 21 points and the Nasdaq completed the green sweep, adding 87 points to close at 9,725. Oil picked up further after hours to trade at $56 per barrel, whilst global concerns saw safe haven gold rally back to recent high of $1575.
Barclays reported a better than expected profit before tax of £6.2bn for 2019, which was above the average analysts forecasts of £5.7bn. Barclays also stated that the FCA are investigating their CEO’s (Mr Staley) ties to Mr. Epstein. The investigation is ongoing and Mr Staley retains the full confidence of the board during this period.
Centrica announce that their annual profit drops 35% hurt by government introduced price cap on energy bills as well as lower natural gas prices. Operating profit fell to £901m from £1.39bn. Centrica says it expects 2020 profit from its core divisions to be in line with 2019, but warned upstream earnings may be hit hard by lower commodity prices.
Coca-Cola HBC posts higher profit and sees faster growth in 2020. Profits rise +11.9% to 715.3m euros helped by demand in emerging markets like Nigeria and Romania.
Indivior posts quarterly loss and had forecast lower 2020 revenue after its opioid addiction treatment lost more than half of its market share to rivals in the US, its biggest market. The loss came in at $55m compared to a profit of $24m a year earlier.
Source: Bloomberg, FT, Reuters, DJ Newswires, AlphaTerminal
Bank Of Georgia, Barclays, Centrica, Coca-Cola HSBC, Indivior, Relx, MJ Gleeson, Great Portland Estates, Just Eat, Lancashire Holdings, SolGold
Astrazeneca, Royal Bank Of Scotland, Segro
EU - German Harmonised index of consumer price
US - Consumer Price Index
UK 100 :
Royal Dutch Shell A
Royal Dutch Shell B
BP
Polymetal
Hargreaves Lansdown
:
PZ Cussons
Greencoat UK Wind
Rank Group
Mondi Downgraded to Add by Investec (Bloomberg: 10 Buys/ 5 Holds/ 1 Sells)
NMC Health Downgraded to Sell by Societe Generale (Bloomberg: 4 Buys/ 0 Holds/ 2 Sells)
For any help you may require placing trades or in terms of market information, put a call in to our trading floor – it’s all part of the service.
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.